Eric Mittleberg

Eric Mittleberg has had a diverse work experience in the pharmaceutical industry. Eric started their career at Lederle as a Supervisor in 1978. Later, they joined Sandoz as the VP of Product Development, where they worked from 2009 to 2012. In 2013, Eric Mittleberg moved to Nostrum Pharmaceuticals as the COO, and the following year, they held the same role at Nostrum Laboratories. Finally, Eric became the Chief Scientific Officer at G&W Laboratories in 2014, where they are currently employed.

Eric Mittleberg has a strong educational background in the field of pharmaceutics and drug design. Eric obtained a PhD and MS in Pharmaceutics and Drug Design from S. John's University. Additionally, they pursued a PhD in Pharmaceutics and Drug Design from St. John's Univ. College of Pharmacy. Eric also holds a BS in Pharmacy from St. John's University. Moreover, they have a MS and PhD in Dosage Form Design, Pharmaceutics, and Biopharmaceutics, which they obtained from St. John's University as well. The provided information does not include specific start and end years for each education experience.